Clinical validation of qPCR Target Selector™ assays using highly specific switch-blockers for rare mutation detection
{{output}}
Aims: The identification of actionable DNA mutations associated with a patient's tumour is critical for devising a targeted, personalised cancer treatment strategy. However, these molecular analyses are typically performed using ... ...
